WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two ...

Jillian Michaels reiterated her stance on the dangers associated with the use of Ozempic, including any health issues that ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

A new study linked weight loss drugs known as semaglutides (Ozempic is one) to a lower risk of opioid overdoses. Doctors tell ...

Ozempic has been called a "wonder drug," with a growing body of research showing that it may help treat a huge range of ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

Hundreds of Americans have jumped on a multi-state lawsuit alleging that the makers of Ozempic and Mounjaro caused ...

(HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster ...

Thousands of plaintiffs across the country claiming in a federal lawsuit that Ozempic, Mounjaro and other popular drugs prescribed for diabetes and obesity harmed their health, and that the ...